Besides, it was also enriched in Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway and IL-17 signaling pathway, which were closely related to immunity, indicating that there might be significant differences in tumor immune microenvironment between high-risk and low-risk patients (Figure 5B). The gene discussed is IL17A; the disease is neoplasm.